+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibiotics Partnering"

Antibiotic Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 100 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Antibiotics Partnering market is a subset of the Infectious Diseases Drugs market, focusing on the development and commercialization of antibiotics. Antibiotics are a type of drug used to treat bacterial infections, and are often used in combination with other drugs to treat more serious infections. The Antibiotics Partnering market is driven by the need for new and improved antibiotics to combat the increasing prevalence of antibiotic-resistant bacteria. Companies in this market are focused on developing new antibiotics, as well as improving existing antibiotics to make them more effective. The Antibiotics Partnering market is highly competitive, with many companies vying for a share of the market. Companies in this market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi, Johnson & Johnson, and Bayer. Show Less Read more